Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lucina BioSciences
Aurora, Colorado, United Stateslucinabio.org ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Commercial
01
Overview
Lucina BioSciences develops, manufactures, and distributes novel placental-derived allograft products using its proprietary Nativus® Processing System. The company focuses on maintaining the natural properties of human placental tissues to enhance patient wellness. Their solutions are used in wound care, orthopedics, ophthalmology, and other areas requiring advanced biologic grafts. They operate under strict GMP/FDA compliance with a focus on quality management.
- Therapeutic areas
- OtherDermatologyOphthalmology
- Modalities
- Placental-derived allograft products (Biologic)Tissue-based therapies (Biologic)Allograft products (Biologic)
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Lucina BioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lucina BioSciences.